The prescription cost of top multinational pharmaceutical companies shows increasing trend

According to the analysis of prescription cost of top 18 multinational pharmaceutical companies, their prescription cost from January to April 2014 increased by 4.5%, from 774.2 billion won in the previous year to 808.8 billion won. On the other hand, the prescription cost of domestic pharmaceutical companies showed decreasing trend, especially for top domestic companies.

Among top 18 multinat...